AG
Agenus Inc.
AGEN · NASDAQ
$7.85 +3.29% (+$0.25)
1M +2.35%
Market Cap $300.7M
P/E Ratio 3.27x
Div. Yield -
ROE -
Bulios Fair Price
$4.48
42.9% downside
Current Price
$7.85
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AGEN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
95 /100
Cheap P/E 3.27x
P/S 2.27x
EV/EBITDA 2.07x
Growth
46 /100
Stable Rev. growth 5.22%
EPS growth N/A
Book val. growth N/A
Profitability
70 /100
Strong Gross margin 75.63%
FCF margin 74.23%
Net margin 69.34%
Quality
35 /100
Average ROIC 129.48%
Asset turnover 0.77x
ROA 53.28%
Debt
59 /100
Moderate Current ratio 0.34x
Net debt/EBITDA 0.14x
Int. coverage 2.56x
Stability
22 /100
Unstable Beta 1.55x
Profitable years 1
Rev. volatility 46.66%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AGEN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Garo H. Armen
Employees
81
Headquarters
Lexington
Upcoming events
09 NOV
Earnings
Upcoming earnings report